Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Rivaroxaban is an oral anticoagulant invented and manufactured by J&J; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
This report elaborates on the current development of the Rivaroxaban industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
J&J
Bayer
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
10 mg
15 mg
20 mg
Application:
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Rivaroxaban Industry Overview
-
1.1.1 Rivaroxaban Market Scope and Market Segments
-
1.1.2 Rivaroxaban Industry Characteristics
-
1.1.3 Global and China Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Rivaroxaban Production Value and Growth Rate (2017-2028)
-
1.2 Global Rivaroxaban Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 10 mg
-
1.2.2 15 mg
-
1.2.3 20 mg
-
1.3 Global Rivaroxaban Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Acute Coronary Syndrome (ACS)
-
1.3.2 Venous Thromboembolism (VTE)
-
1.4 Market Analysis by Region
-
1.4.1 North America Rivaroxaban Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Rivaroxaban Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Rivaroxaban Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Rivaroxaban Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Rivaroxaban Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Rivaroxaban Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Rivaroxaban Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Rivaroxaban Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Rivaroxaban Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Rivaroxaban Industry Porter's Five Forces Model Analysis
-
2.2.3 Rivaroxaban Industry PEST Analysis
-
2.3 Rivaroxaban Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Rivaroxaban Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Rivaroxaban Industry
Chapter 3 Global and China Rivaroxaban Market, by Manufacturer
-
3.1 Global and China Rivaroxaban Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Rivaroxaban Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Rivaroxaban Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Rivaroxaban Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Rivaroxaban Market Top 3 Players
Chapter 4 Global and China Rivaroxaban Market, by Type (2017-2028)
-
4.1 Rivaroxaban Market Trend, by Type
-
4.2 Global Rivaroxaban Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Rivaroxaban Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Rivaroxaban Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Rivaroxaban Price Trend, by Type (2017-2028)
-
4.3 China Rivaroxaban Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Rivaroxaban Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Rivaroxaban Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Rivaroxaban Price Trend, by Type (2017-2028)
Chapter 5 Global and China Rivaroxaban Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Rivaroxaban Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Rivaroxaban Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Rivaroxaban Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Rivaroxaban Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Rivaroxaban Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Rivaroxaban Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Rivaroxaban Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Rivaroxaban Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Rivaroxaban Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Rivaroxaban Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Rivaroxaban Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Rivaroxaban Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Rivaroxaban Market Analysis
-
7.1 North America Rivaroxaban Market, by Type
-
7.2 North America Rivaroxaban Market, by Application
-
7.3 North America Rivaroxaban Market Analysis and Forecast, by Country
-
7.3.1 United States Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Rivaroxaban Market Analysis
-
8.1 Europe Rivaroxaban Market, by Type
-
8.2 Europe Rivaroxaban Market, by Application
-
8.3 Europe Rivaroxaban Market Analysis and Forecast, by Country
-
8.3.1 Germany Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Rivaroxaban Market Analysis
-
9.1 APAC Rivaroxaban Market, by Type
-
9.2 APAC Rivaroxaban Market, by Application
-
9.3 APAC Rivaroxaban Market Analysis and Forecast, by Country
-
9.3.1 China Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Rivaroxaban Market Analysis
-
10.1 Latin America, Middle East and Africa Rivaroxaban Market, by Type
-
10.2 Latin America, Middle East and Africa Rivaroxaban Market, by Application
-
10.3 Latin America, Middle East and Africa Rivaroxaban Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Rivaroxaban Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Rivaroxaban Company Profiles
-
11.1 J&J
-
11.1.1 J&J Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 J&J Rivaroxaban Product Profiles, Application and Specification
-
11.1.3 J&J Rivaroxaban Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Bayer
-
11.2.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Bayer Rivaroxaban Product Profiles, Application and Specification
-
11.2.3 Bayer Rivaroxaban Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Rivaroxaban Industry Investment Prospect and Risk Assessment
-
12.1 Rivaroxaban Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Rivaroxaban Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure China Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Global Rivaroxaban Production Value and Growth Rate (2017-2028)
-
Figure China Rivaroxaban Production Value and Growth Rate (2017-2028)
-
Figure Global Rivaroxaban Market Size and Growth Rate of 10 mg (2017-2028)
-
Figure Global Rivaroxaban Market Size and Growth Rate of 15 mg (2017-2028)
-
Figure Global Rivaroxaban Market Size and Growth Rate of 20 mg (2017-2028)
-
Figure Global Rivaroxaban Market Size and Growth Rate of Acute Coronary Syndrome (ACS) (2017-2028)
-
Figure Global Rivaroxaban Market Size and Growth Rate of Venous Thromboembolism (VTE) (2017-2028)
-
Figure North America Rivaroxaban Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Rivaroxaban Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Rivaroxaban Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Rivaroxaban Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Rivaroxaban Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Rivaroxaban Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Rivaroxaban Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Rivaroxaban Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Rivaroxaban Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Rivaroxaban Market Share, by Manufacturer in 2021
-
Figure Global and China Rivaroxaban Market Share, by Manufacturer in 2022
-
Table Global Rivaroxaban Sales Volume, by Type (2017-2028)
-
Table Global Rivaroxaban Sales Volume Share, by Type (2017-2028)
-
Figure Global Rivaroxaban Sales Volume Share, by Type (2017-2028)
-
Table Global Rivaroxaban Sales Value, by Type (2017-2028)
-
Table Global Rivaroxaban Sales Value Share, by Type (2017-2028)
-
Figure Global Rivaroxaban Price Trend, by Type (2017-2028)
-
Table China Rivaroxaban Sales Volume, by Type (2017-2028)
-
Table China Rivaroxaban Sales Volume Share, by Type (2017-2028)
-
Figure China Rivaroxaban Sales Volume Share, by Type (2017-2028)
-
Table China Rivaroxaban Sales Value, by Type (2017-2028)
-
Table China Rivaroxaban Sales Value Share, by Type (2017-2028)
-
Figure China Rivaroxaban Price Trend, by Type (2017-2028)
-
Table Global Rivaroxaban Sales Volume, by Application (2017-2028)
-
Table Global Rivaroxaban Sales Volume Share, by Application (2017-2028)
-
Figure Global Rivaroxaban Sales Volume Share, by Application (2017-2028)
-
Table Global Rivaroxaban Sales Value, by Application (2017-2028)
-
Table Global Rivaroxaban Sales Value Share, by Application (2017-2028)
-
Figure Global Rivaroxaban Sales Value Share, by Application (2017-2028)
-
Table China Rivaroxaban Sales Volume, by Application (2017-2028)
-
Table China Rivaroxaban Sales Volume Share, by Application (2017-2028)
-
Figure China Rivaroxaban Sales Volume Share, by Application (2017-2028)
-
Table China Rivaroxaban Sales Value, by Application (2017-2028)
-
Table China Rivaroxaban Sales Value Share, by Application (2017-2028)
-
Figure China Rivaroxaban Sales Value Share, by Application (2017-2028)
-
Figure China Rivaroxaban Production, Import, Consumption and Export (2017-2022)
-
Figure North America Rivaroxaban Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Rivaroxaban Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Rivaroxaban Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Rivaroxaban Production, Import, Consumption and Export (2017-2022)
-
Table North America Rivaroxaban Sales Volume, by Type (2017-2028)
-
Table North America Rivaroxaban Sales Volume Share, by Type (2017-2028)
-
Figure North America Rivaroxaban Sales Volume Share, by Type (2017-2028)
-
Table North America Rivaroxaban Sales Volume, by Application (2017-2028)
-
Table North America Rivaroxaban Sales Volume Share, by Application (2017-2028)
-
Figure North America Rivaroxaban Sales Volume Share, by Application (2017-2028)
-
Figure United States Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure United States Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure Canada Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Table Europe Rivaroxaban Sales Volume, by Type (2017-2028)
-
Table Europe Rivaroxaban Sales Volume Share, by Type (2017-2028)
-
Figure Europe Rivaroxaban Sales Volume Share, by Type (2017-2028)
-
Table Europe Rivaroxaban Sales Volume, by Application (2017-2028)
-
Table Europe Rivaroxaban Sales Volume Share, by Application (2017-2028)
-
Figure Europe Rivaroxaban Sales Volume Share, by Application (2017-2028)
-
Figure Germany Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure UK Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure UK Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure France Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure France Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure Italy Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure Spain Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure Poland Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure Russia Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Table APAC Rivaroxaban Sales Volume, by Type (2017-2028)
-
Table APAC Rivaroxaban Sales Volume Share, by Type (2017-2028)
-
Figure APAC Rivaroxaban Sales Volume Share, by Type (2017-2028)
-
Table APAC Rivaroxaban Sales Volume, by Application (2017-2028)
-
Table APAC Rivaroxaban Sales Volume Share, by Application (2017-2028)
-
Figure APAC Rivaroxaban Sales Volume Share, by Application (2017-2028)
-
Figure China Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure China Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure Japan Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure India Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure India Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Rivaroxaban Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Rivaroxaban Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Rivaroxaban Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Rivaroxaban Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Rivaroxaban Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Rivaroxaban Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Rivaroxaban Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Rivaroxaban Sales Value and Growth Rate (2017-2028)
-
Table J&J Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table J&J Product Profiles, Application and Specification
-
Table J&J Rivaroxaban Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bayer Product Profiles, Application and Specification
-
Table Bayer Rivaroxaban Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
